Anthrax physical examination: Difference between revisions

Jump to navigation Jump to search
Line 21: Line 21:
* [[Edema]] may be present
* [[Edema]] may be present
* Regional [[lymphadenitis]] may be present
* Regional [[lymphadenitis]] may be present
Shown below are images of the development and resolution of uncomplicated cutaneous anthrax lesion.
<gallery>
Image:Cutaneous A1.png| Day 1 of development and resolution of uncomplicated cutaneous anthrax lesion.”<SMALL><SMALL>''[http://www.who.int/en//  Adapted from World Health Organization (WHO)]''<ref name="WHO">{{Cite web | title = World Health Organization | url = http://www.who.int/en/}}</ref></SMALL></SMALL>
Image:CutaneousA2.png| Day 2 - 3 of development and resolution of uncomplicated cutaneous anthrax lesion.”<SMALL><SMALL>''[http://www.who.int/en//  Adapted from World Health Organization (WHO)]''<ref name="WHO">{{Cite web | title = World Health Organization | url = http://www.who.int/en/}}</ref></SMALL></SMALL>
Image:CutaneousA3.png| Day 4 of development and resolution of uncomplicated cutaneous anthrax lesion.”<SMALL><SMALL>''[http://www.who.int/en//  Adapted from World Health Organization (WHO)]''<ref name="WHO">{{Cite web | title = World Health Organization | url = http://www.who.int/en/}}</ref></SMALL></SMALL>
Image:CutaneousA4.png| Day 6 of development and resolution of uncomplicated cutaneous anthrax lesion.”<SMALL><SMALL>''[http://www.who.int/en//  Adapted from World Health Organization (WHO)]''<ref name="WHO">{{Cite web | title = World Health Organization | url = http://www.who.int/en/}}</ref></SMALL></SMALL>
Image:CutaneousA5.png| Day 11 of development and resolution of uncomplicated cutaneous anthrax lesion.”<SMALL><SMALL>''[http://www.who.int/en//  Adapted from World Health Organization (WHO)]''<ref name="WHO">{{Cite web | title = World Health Organization | url = http://www.who.int/en/}}</ref></SMALL></SMALL>
</gallery>


===Neck===
===Neck===

Revision as of 11:02, 19 July 2014

Anthrax Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Anthrax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anthrax physical examination On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anthrax physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anthrax physical examination

CDC on Anthrax physical examination

Anthrax physical examination in the news

Blogs on Anthrax physical examination

Directions to Hospitals Treating Anthrax

Risk calculators and risk factors for Anthrax physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

The physical findings of anthrax infection depend on the mode of anthrax exposure in the patient (cutaneous, ingestion, inhalation, injection). Common findings associated with cutaneous anthrax infection include fever, tachycardia, skin rash with formation of a typical scar, edema and lymphadenopathy; with gastrointestinal anthrax infection include fever, tachycardia, mucosal ulcer and edema in case of oropharyngeal lesion and edema and pallor in more severe cases; with inhalation anthrax infection includes: fever, tachycardia, bradypnea in severe cases, pallor, cyanosis and decreased heart and lung sounds in the presence of pleural effusion; and with anthrax infection due to injection include fever, typical skin scar at the site of injection, edema and subcutaneous and/or muscular abscess.

Cutaneous Anthrax

Vitals

Temperature

Pulse

Blood Pressure

Skin

  • A rash is often present.
    • The rash initially appears as a small papule. A ring of vesicles develops around the papule, often with exudate. Between days 5 - 7, the initial papule ulcerates to form a typical scar.
    • Cutaneous lesions are single, but sometimes two or more lesions are present.
    • Cutaneous lesions are seen on exposed unprotected regions of the body, mostly on the face, neck, hands and wrists.
  • Edema may be present
  • Regional lymphadenitis may be present

Shown below are images of the development and resolution of uncomplicated cutaneous anthrax lesion.

Neck

  • Lymphadenopathy may be present, particularly if initial lesion is located near the neck

Abdomen

Extremities

  • Edema may be present, particularly around the site of the initial lesion

Neurologic

  • The mental status may be altered in case of severe systemic anthrax

Gastrointestinal Anthrax

Vitals

Temperature

Blood Pressure

Respiratory Rate

Skin

  • Edema may be present, particularly in the neck region
  • Pallor may be present in cases of systemic anthrax with shock

Throat

Neck

Abdomen

Extremities

Neurologic

  • The mental status may be altered in case of severe systemic anthrax
  • Coma may be present

Inhalation Anthrax

Vitals

Temperature

Blood Pressure

Respiratory Rate

  • Bradypnea may be present in more severe cases

Skin

Neck

Auscultation

Extremities

Neurologic

  • The mental status may be altered in case of severe systemic anthrax
  • Coma may be present

Injection Anthrax

Vitals

Temperature

Pulse

Blood Pressure

Skin

  • A rash is often present. The rash initially appears as a group of small blisters located on the site of injection. Afterwards, a skin sore with black center replaces the blisters, surrounded by an area of edema
  • Regional lymphadenitis may be present
  • A nodular abscess is often palpated on the site where the drug was injected

Neck

  • Lymphadenopathy may be present, particularly if the initial lesion is located in that region

Abdomen

Extremities

  • Edema may be present, particularly around the initial lesion

Neurologic

  • The mental status may be altered in case of severe systemic anthrax

References

  1. 1.0 1.1 1.2 1.3 1.4 "World Health Organization".